Suppr超能文献

招募 BRCA1 限制了 RNA 聚合酶停滞的 MYCN 驱动积累。

Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymerase.

机构信息

Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.

Cancer Systems Biology Group, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.

出版信息

Nature. 2019 Mar;567(7749):545-549. doi: 10.1038/s41586-019-1030-9. Epub 2019 Mar 20.

Abstract

MYC is an oncogenic transcription factor that binds globally to active promoters and promotes transcriptional elongation by RNA polymerase II (RNAPII). Deregulated expression of the paralogous protein MYCN drives the development of neuronal and neuroendocrine tumours and is often associated with a particularly poor prognosis. Here we show that, similar to MYC, activation of MYCN in human neuroblastoma cells induces escape of RNAPII from promoters. If the release of RNAPII from transcriptional pause sites (pause release) fails, MYCN recruits BRCA1 to promoter-proximal regions. Recruitment of BRCA1 prevents MYCN-dependent accumulation of stalled RNAPII and enhances transcriptional activation by MYCN. Mechanistically, BRCA1 stabilizes mRNA decapping complexes and enables MYCN to suppress R-loop formation in promoter-proximal regions. Recruitment of BRCA1 requires the ubiquitin-specific protease USP11, which binds specifically to MYCN when MYCN is dephosphorylated at Thr58. USP11, BRCA1 and MYCN stabilize each other on chromatin, preventing proteasomal turnover of MYCN. Because BRCA1 is highly expressed in neuronal progenitor cells during early development and MYC is less efficient than MYCN in recruiting BRCA1, our findings indicate that a cell-lineage-specific stress response enables MYCN-driven tumours to cope with deregulated RNAPII function.

摘要

MYC 是一种致癌转录因子,它可以与活性启动子广泛结合,并通过 RNA 聚合酶 II(RNAPII)促进转录延伸。同源蛋白 MYCN 的表达失调会导致神经元和神经内分泌肿瘤的发生,并且通常与预后不良有关。在这里,我们表明,类似于 MYC,在人类神经母细胞瘤细胞中激活 MYCN 会诱导 RNAPII 从启动子逃脱。如果 RNAPII 从转录暂停位点(暂停释放)释放失败,MYCN 会将 BRCA1 募集到启动子近端区域。BRCA1 的募集可防止 MYCN 依赖性停滞 RNAPII 的积累,并增强 MYCN 的转录激活。从机制上讲,BRCA1 稳定了 mRNA 去帽复合物,并使 MYCN 能够抑制启动子近端区域的 R 环形成。BRCA1 的募集需要泛素特异性蛋白酶 USP11,当 MYCN 在 Thr58 去磷酸化时,USP11 特异性地与 MYCN 结合。USP11、BRCA1 和 MYCN 在染色质上相互稳定,从而阻止 MYCN 的蛋白酶体降解。由于 BRCA1 在早期发育过程中在神经元祖细胞中高度表达,而 MYC 比 MYCN 更有效地募集 BRCA1,因此我们的研究结果表明,细胞谱系特异性应激反应使 MYCN 驱动的肿瘤能够应对失调的 RNAPII 功能。

相似文献

1
Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymerase.
Nature. 2019 Mar;567(7749):545-549. doi: 10.1038/s41586-019-1030-9. Epub 2019 Mar 20.
2
MYCN recruits the nuclear exosome complex to RNA polymerase II to prevent transcription-replication conflicts.
Mol Cell. 2022 Jan 6;82(1):159-176.e12. doi: 10.1016/j.molcel.2021.11.002. Epub 2021 Nov 29.
5
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma.
Nat Genet. 2018 Apr;50(4):515-523. doi: 10.1038/s41588-018-0044-9. Epub 2018 Jan 29.
6
CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Oncogene. 2016 Jul 7;35(27):3565-76. doi: 10.1038/onc.2015.422. Epub 2015 Nov 9.
7
Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma.
Cancer Res. 2006 Aug 15;66(16):8100-8. doi: 10.1158/0008-5472.CAN-05-4519.
8
Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation.
Mol Cell. 2016 Jan 7;61(1):54-67. doi: 10.1016/j.molcel.2015.11.007. Epub 2015 Dec 10.
10
The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex.
Mol Cell. 2024 Jun 6;84(11):2070-2086.e20. doi: 10.1016/j.molcel.2024.04.007. Epub 2024 May 3.

引用本文的文献

2
MYC: The Guardian of Its Own Chaos.
Bioessays. 2025 Jul;47(7):e70010. doi: 10.1002/bies.70010. Epub 2025 Jun 9.
5
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.
Cancer Discov. 2025 Mar 3;15(3):461-480. doi: 10.1158/2159-8290.CD-24-1326.
6
DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization.
Theranostics. 2025 Jan 20;15(6):2375-2392. doi: 10.7150/thno.102730. eCollection 2025.
7
Tolerance of Oncogene-Induced Replication Stress: A Fuel for Genomic Instability.
Cancers (Basel). 2024 Oct 17;16(20):3507. doi: 10.3390/cancers16203507.
10
Immune evasion: An imperative and consequence of MYC deregulation.
Mol Oncol. 2024 Oct;18(10):2338-2355. doi: 10.1002/1878-0261.13695. Epub 2024 Jul 2.

本文引用的文献

1
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis.
Science. 2018 May 18;360(6390):800-805. doi: 10.1126/science.aao2793. Epub 2018 Apr 5.
2
EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.
Nature. 2018 Mar 15;555(7696):387-391. doi: 10.1038/nature25748. Epub 2018 Mar 7.
3
Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1.
Nat Commun. 2018 Mar 6;9(1):967. doi: 10.1038/s41467-018-03433-3.
4
The Expanding World of N-MYC-Driven Tumors.
Cancer Discov. 2018 Feb;8(2):150-163. doi: 10.1158/2159-8290.CD-17-0273. Epub 2018 Jan 22.
6
Replication Fork Reversal: Players and Guardians.
Mol Cell. 2017 Dec 7;68(5):830-833. doi: 10.1016/j.molcel.2017.11.022.
7
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.
Cell. 2017 Nov 30;171(6):1301-1315.e14. doi: 10.1016/j.cell.2017.11.013.
8
R-ChIP Using Inactive RNase H Reveals Dynamic Coupling of R-loops with Transcriptional Pausing at Gene Promoters.
Mol Cell. 2017 Nov 16;68(4):745-757.e5. doi: 10.1016/j.molcel.2017.10.008. Epub 2017 Nov 2.
9
Integrative analysis of RNA polymerase II and transcriptional dynamics upon MYC activation.
Genome Res. 2017 Oct;27(10):1658-1664. doi: 10.1101/gr.226035.117. Epub 2017 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验